NBT Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Sell
2,911
-461
-14% -$36.9K 0.01% 374
2025
Q4
$322K Hold
3,372
0.02% 318
2025
Q3
$329K Sell
3,372
-470
-12% -$48.7K 0.02% 317
2025
Q2
$413K Buy
3,842
+153
+4% +$15.5K 0.03% 293
2025
Q1
$372K Hold
3,689
0.03% 302
2024
Q4
$330K Sell
3,689
-10
-0.3% -$880 0.02% 311
2024
Q3
$310K Sell
3,699
-1,096
-23% -$86.4K 0.02% 333
2024
Q2
$369K Buy
4,795
+10
+0.2% +$732 0.03% 305
2024
Q1
$328K Sell
4,785
-327
-6% -$21K 0.02% 320
2023
Q4
$296K Buy
5,112
+327
+7% +$17.5K 0.02% 325
2023
Q3
$253K Buy
+4,785
New +$251K 0.02% 284

Other funds holding BSX

NBT Bank's BSX Position: Q1 2026 in Review

NBT Bank reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $36.9K and leaving 2,911 shares worth $183K. The position accounts for 0.01% of the portfolio, ranked #374.

NBT Bank first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $413K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • NBT Bank held 2,911 shares of Boston Scientific worth $183K as of Q1 2026.
  • NBT Bank sold 461 Boston Scientific shares in Q1 2026, an estimated $36.9K.
  • Boston Scientific made up 0.01% of NBT Bank's portfolio in Q1 2026, its #374 holding.
  • NBT Bank first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
  • NBT Bank's Boston Scientific position peaked at $413K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.